21/01/2026
Multiple sclerosis care today primarily focuses on reducing overactive immune responses and inflammatory activity that damages myelin.
Mesenchymal stem cells (MSCs)—including our proprietary Golden Cells™, are being studied for their potential to modulate immune responses and secrete trophic factors and bioactive molecules that may help tissue regeneration throughout the body, including the nervous system. While research continues to evolve, this dual focus on immune regulation and tissue support has led to improvements in observed clinical outcomes.
Ready to learn more about our approach? Visit our website: https://loom.ly/9TBCScs